Martin Hutchings, MD, PhD Rigshospitalet, Copenhagen Denmark 5Live #ASCO20
6:23
Key Insights on Epcoritamab (GEN3013; DuoBody-CD3×CD20) to induce complete response in patients with relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL): Complete dose escalation data and efficacy results from a phase I/II trial.
Mantle Cell Lymphoma
Martin Hutchings, MD, PhD Rigshospitalet, Copenhagen Denmark 5Live #ASCO20
Key Insights on Epcoritamab (GEN3013; DuoBody-CD3×CD20) to induce complete response in patients with relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL): Complete dose escalation data and efficacy results from a phase I/II trial.
Mantle Cell Lymphoma Similar Videos
Similar Videos
